A detailed history of High Mark Wealth Management LLC transactions in Axonics, Inc. stock. As of the latest transaction made, High Mark Wealth Management LLC holds 175 shares of AXNX stock, worth $12,421. This represents 0.01% of its overall portfolio holdings.

Number of Shares
175
Previous 175 -0.0%
Holding current value
$12,421
Previous $11,000 9.09%
% of portfolio
0.01%
Previous 0.01%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 29, 2024

SELL
$66.47 - $69.65 $23,264 - $24,377
-350 Reduced 66.67%
175 $11,000
Q3 2023

Oct 18, 2023

BUY
$48.64 - $62.51 $17,024 - $21,878
350 Added 200.0%
525 $29,000
Q4 2021

Jan 20, 2022

SELL
$50.01 - $73.35 $14,402 - $21,124
-288 Reduced 62.2%
175 $10,000
Q3 2021

Nov 01, 2021

BUY
$59.21 - $78.66 $2,368 - $3,146
40 Added 9.46%
463 $30,000
Q2 2021

Aug 02, 2021

BUY
$51.39 - $66.9 $1,798 - $2,341
35 Added 9.02%
423 $27,000
Q1 2021

Apr 22, 2021

BUY
$49.14 - $59.89 $19,066 - $23,237
388 New
388 $23,000

Others Institutions Holding AXNX

About Axonics, Inc.


  • Ticker AXNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 49,123,600
  • Market Cap $3.49B
  • Description
  • Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...
More about AXNX
Track This Portfolio

Track High Mark Wealth Management LLC Portfolio

Follow High Mark Wealth Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of High Mark Wealth Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on High Mark Wealth Management LLC with notifications on news.